Law360, New York (June 24, 2005) -- Brazil has vowed to break the patent on U.S. drug maker Abbott Laboratories' HIV drug Kaletra in an effort to cut treatment costs.
Brazilian Health Minister Humberto Costa told local media his government would break the patent as a matter of “public interest.”...


